Top compounds associated with response to PRAMEF12


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.077 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.12 0.1
mRNA 968 CTRPv2 pan-cancer AAC 0.11 0.1
mRNA BIRB 0796 FIMM pan-cancer AAC 0.28 0.1
mRNA ML320 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA lenalidomide FIMM pan-cancer AAC 0.25 0.1
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.049 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.1
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.077 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
Download CSV